Literature DB >> 24034298

Research misconduct and scientific integrity: a call for a global forum.

Tetsuya Tanimoto, Masahiro Kami, Kenji Shibuya.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24034298     DOI: 10.1016/S0140-6736(13)61933-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Implementation of Japan's First Clinical Research Regulatory Law: Background, Overview, and Challenges.

Authors:  Akira Akabayashi; Eisuke Nakazawa; Aru Akabayashi
Journal:  HEC Forum       Date:  2019-12

Review 2.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

3.  Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal.

Authors:  Yuya Sugawara; Tetsuya Tanimoto; Shoko Miyagawa; Masayasu Murakami; Atsushi Tsuya; Atsushi Tanaka; Masahiro Kami; Hiroto Narimatsu
Journal:  J Med Internet Res       Date:  2017-02-28       Impact factor: 5.428

4.  Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.

Authors:  Hiroaki Saito; Akihiko Ozaki; Toyoaki Sawano; Yuki Shimada; Tetsuya Tanimoto
Journal:  JAMA Netw Open       Date:  2019-04-05

5.  Regulatory changes after the enforcement of the new Clinical Trials Act in Japan.

Authors:  Kenichi Nakamura; Taro Shibata
Journal:  Jpn J Clin Oncol       Date:  2020-04-07       Impact factor: 3.019

6.  The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective.

Authors:  Hideki Maeda
Journal:  Front Med (Lausanne)       Date:  2022-01-13

Review 7.  Overview of the ethical guidelines for medical and biological research involving human subjects in Japan.

Authors:  Junko Eba; Kenichi Nakamura
Journal:  Jpn J Clin Oncol       Date:  2022-05-31       Impact factor: 2.925

Review 8.  Are Japanese randomized controlled trials up to the task? A systematic review.

Authors:  Daisuke Yoneoka; Akinori Hisashige; Erika Ota; Karin Miyamoto; Shuhei Nomura; Miwako Segawa; Stuart Gilmour; Kenji Shibuya
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.